Events

Optima to host post-conference workshop at Lyophilization USA

23 - 24 October 2019, Boston, USA.
Delegates for the 5th Annual Lyophilization USA conference, taking place in Boston, will have the opportunity to attend the half-day post-conference workshop titled "Current and Future Freeze-Drying Technologies and Methods" led by Dena Flamm and Alexander Tambovzev on October 25th 2019.

Ophthalmic Drugs Conference 2019

19 - 20 November 2019, London, UK.
The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.

Lyophilization USA Conference 2019

23 - 24 October 2019, Boston, USA.
The current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution.

Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference

21 - 22 October 2019, Boston, USA.
The inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies, oncolytic viral complexes and hormones.

Wearable Injectors and Connected Devices Conference 2019

9 - 10 October 2019, London, UK.
SMi is proud to present the inaugural Wearable Injectors and Connected Devices Conference, taking place in London. The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.

Highly Potent APIs 2019 Conference

13 - 14 May 2019, London, UK.
The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.

SMi's 9th Annual Conference: Biobanking 2019

25 - 26 September 2019, London, UK.
With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020, backed by an explosive CAGR of 9.5% between now and 2026. This market growth is fuelled by the increasing drive towards precision and personalised medicine and thus, quality biosamples are now in soaring demand.

Events

More Pharma News ...